Search research articles
Contact Us
Filters
Showing results (151-160 of 250) with videos related to
Page
of 25
Sort By:
Blood
|
September 1, 1995
Prevalence of heterozygotes for hemochromatosis in the white population of the United States
C E McLaren, V R Gordeuk, A C Looker, et al.
NEJM Catalyst Innovations in Care Delivery
|
November 19, 2025
Reduced Hospital Readmissions Through Personalized Care: Implementation of a Patient, Risk-Focused Hospital-Wide Discharge Care Center
Jennifer B Barrett, Ashley Trambley, Emily K Blessinger, et al.
Journal of Thrombosis and Thrombolysis
|
June 4, 2014
Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review
Jeffrey B Washam, Rowena J Dolor, W Schuyler Jones, et al.
International Journal of Cardiology
|
March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis
Alexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
American Heart Journal
|
March 29, 2008
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale
Rajendra H Mehta, John H Alexander, Robert Emery, et al.
Annals of Internal Medicine
|
February 12, 1998
The Stroke Prevention Policy Model: linking evidence and clinical decisions
D B Matchar, G P Samsa, J R Matthews, et al.
The American Journal of Cardiology
|
September 16, 2003
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions
David F Kong, Vic Hasselblad, Robert A Harrington, et al.
The American Journal of Cardiology
|
October 24, 2007
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)
Monica R Shah, Vic Hasselblad, Gudaye Tasissa, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 30, 2007
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
Jean-Claude Tardif, Michel Carrier, David E Kandzari, et al.
American Journal of Obstetrics and Gynecology
|
June 26, 2003
Tocolytic treatment for the management of preterm labor: a review of the evidence
Nancy D Berkman, John M Thorp, Kathleen N Lohr, et al.
Page
of 25
Search research articles
Search
Showing results (151-160 of 250) with videos related to
Sort By:
Page
of 25
Blood
|
September 1, 1995
Prevalence of heterozygotes for hemochromatosis in the white population of the United States
C E McLaren, V R Gordeuk, A C Looker, et al.
NEJM Catalyst Innovations in Care Delivery
|
November 19, 2025
Reduced Hospital Readmissions Through Personalized Care: Implementation of a Patient, Risk-Focused Hospital-Wide Discharge Care Center
Jennifer B Barrett, Ashley Trambley, Emily K Blessinger, et al.
Journal of Thrombosis and Thrombolysis
|
June 4, 2014
Dual antiplatelet therapy with or without oral anticoagulation in the postdischarge management of acute coronary syndrome patients with an indication for long term anticoagulation: a systematic review
Jeffrey B Washam, Rowena J Dolor, W Schuyler Jones, et al.
International Journal of Cardiology
|
March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis
Alexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
American Heart Journal
|
March 29, 2008
A randomized, double-blind, placebo-controlled, multicenter study to evaluate the cardioprotective effects of MC-1 in patients undergoing high-risk coronary artery bypass graft surgery: MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery Trial (MEND-CABG) II--study design and rationale
Rajendra H Mehta, John H Alexander, Robert Emery, et al.
Annals of Internal Medicine
|
February 12, 1998
The Stroke Prevention Policy Model: linking evidence and clinical decisions
D B Matchar, G P Samsa, J R Matthews, et al.
The American Journal of Cardiology
|
September 16, 2003
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions
David F Kong, Vic Hasselblad, Robert A Harrington, et al.
The American Journal of Cardiology
|
October 24, 2007
Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial)
Monica R Shah, Vic Hasselblad, Gudaye Tasissa, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
May 30, 2007
Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study
Jean-Claude Tardif, Michel Carrier, David E Kandzari, et al.
American Journal of Obstetrics and Gynecology
|
June 26, 2003
Tocolytic treatment for the management of preterm labor: a review of the evidence
Nancy D Berkman, John M Thorp, Kathleen N Lohr, et al.
Page
of 25